Related Experiment Video
Updated: Mar 11, 2026

07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
946
Pituitary dysfunction after traumatic brain injury: are there definitive data in children?
1Pediatric Endocrinology Unit, Institut de Recerca Pediàtrica Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Archives of Disease in Childhood
|November 23, 2016
Summary
Traumatic brain injury (TBI) survivors, especially children, face a high risk of pituitary dysfunction. Early screening and reassessment are crucial due to common hormone deficiencies like growth hormone and ACTH.
Area of Science:
- Pediatric Endocrinology
- Neuroendocrinology
- Traumatology
Background:
- Traumatic brain injury (TBI) can lead to pituitary dysfunction in both adults and children.
- An international consensus recommends follow-up for TBI survivors due to this risk.
- Previous studies have described the occurrence of hypopituitarism post-TBI.
Purpose of the Study:
- To review and compare published studies on pediatric hypopituitarism following TBI.
- To highlight the prevalence, common deficiencies, and lack of identified risk factors.
- To emphasize the need for standardized follow-up and screening protocols.
Main Methods:
- Systematic review of published pediatric studies on hypopituitarism after TBI.
- Comparative analysis of reported prevalence and types of pituitary hormone deficiencies.
- Evaluation of current follow-up strategies and identification of research gaps.
Main Results:
- Prevalence of hypopituitarism post-TBI in children ranges widely from 5% to 57%.
- Growth hormone (GH) and ACTH deficiencies are most common, followed by gonadotropin and TSH deficiencies.
- Pediatric studies have not identified specific risk factors, and follow-up protocols are inconsistent.
Conclusions:
- Pituitary dysfunction is a frequent and often unrecognized complication in children after TBI.
- Baseline screening and reassessment at 6-12 months post-TBI are recommended.
- Further prospective studies are needed to understand the natural course and benefits of hormonal replacement therapy.

